Acquisition

Concord Biotech Limited (CONCORDBIO) has announced an investment agreement with FSGE Renewable Power Private Limited, categorised under an acquisition intimation. The company will invest in a Wind Solar Hybrid Power Project designed with a wind capacity of approximately 6.3 MW AC. This strategic move, which follows a previous intimation, marks CONCORDBIO's entry into renewable energy generation. For investors, this signifies the company's commitment to sustainable practices and could lead to long-term operational efficiencies.